224 related articles for article (PubMed ID: 32146213)
1. Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetes.
Song L; Liu C; Yang W; Zhang J; Kong X; Zhang B; Chen X; Wang N; Shen D; Li Z; Jin X; Shuai Y; Wang Y
Comput Methods Programs Biomed; 2020 Jul; 191():105416. PubMed ID: 32146213
[TBL] [Abstract][Full Text] [Related]
2. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.
Wang Y; Zhang J; Zeng F; Wang N; Chen X; Zhang B; Zhao D; Yang W; Cobelli C
Diabetes Technol Ther; 2017 Jan; 19(1):41-48. PubMed ID: 28060528
[TBL] [Abstract][Full Text] [Related]
3. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
4. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
[TBL] [Abstract][Full Text] [Related]
5. Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system.
Garcia-Tirado J; Lv D; Corbett JP; Colmegna P; Breton MD
Comput Methods Programs Biomed; 2021 Nov; 211():106401. PubMed ID: 34560603
[TBL] [Abstract][Full Text] [Related]
6. Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
Dovc K; Piona C; Yeşiltepe Mutlu G; Bratina N; Jenko Bizjan B; Lepej D; Nimri R; Atlas E; Muller I; Kordonouri O; Biester T; Danne T; Phillip M; Battelino T
Diabetes Care; 2020 Jan; 43(1):29-36. PubMed ID: 31575640
[TBL] [Abstract][Full Text] [Related]
7. Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.
Forlenza GP; Cameron FM; Ly TT; Lam D; Howsmon DP; Baysal N; Kulina G; Messer L; Clinton P; Levister C; Patek SD; Levy CJ; Wadwa RP; Maahs DM; Bequette BW; Buckingham BA
Diabetes Technol Ther; 2018 May; 20(5):335-343. PubMed ID: 29658779
[TBL] [Abstract][Full Text] [Related]
8. Incorporating Unannounced Meals and Exercise in Adaptive Learning of Personalized Models for Multivariable Artificial Pancreas Systems.
Hajizadeh I; Rashid M; Turksoy K; Samadi S; Feng J; Sevil M; Hobbs N; Lazaro C; Maloney Z; Littlejohn E; Cinar A
J Diabetes Sci Technol; 2018 Sep; 12(5):953-966. PubMed ID: 30060699
[TBL] [Abstract][Full Text] [Related]
9. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.
Pinsker JE; Lee JB; Dassau E; Seborg DE; Bradley PK; Gondhalekar R; Bevier WC; Huyett L; Zisser HC; Doyle FJ
Diabetes Care; 2016 Jul; 39(7):1135-42. PubMed ID: 27289127
[TBL] [Abstract][Full Text] [Related]
10. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
[TBL] [Abstract][Full Text] [Related]
11. Artificial Pancreas With Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes.
Viñals C; Beneyto A; Martín-SanJosé JF; Furió-Novejarque C; Bertachi A; Bondia J; Vehi J; Conget I; Giménez M
J Clin Endocrinol Metab; 2021 Jan; 106(1):55-63. PubMed ID: 32852548
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
[No Abstract] [Full Text] [Related]
13. Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes.
Capel I; Rigla M; García-Sáez G; Rodríguez-Herrero A; Pons B; Subías D; García-García F; Gallach M; Aguilar M; Pérez-Gandía C; Gómez EJ; Caixàs A; Hernando ME
Diabetes Technol Ther; 2014 Mar; 16(3):172-9. PubMed ID: 24152323
[TBL] [Abstract][Full Text] [Related]
14. A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: announced (with or without bolus reduction) vs unannounced exercise strategies.
Tagougui S; Taleb N; Legault L; Suppère C; Messier V; Boukabous I; Shohoudi A; Ladouceur M; Rabasa-Lhoret R
Diabetologia; 2020 Nov; 63(11):2282-2291. PubMed ID: 32740723
[TBL] [Abstract][Full Text] [Related]
15. Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System.
Shalit R; Minsky N; Laron-Hirsh M; Cohen O; Kurtz N; Roy A; Grosman B; Benedetti A; Tirosh A
Diabetes Technol Ther; 2023 Sep; 25(9):579-588. PubMed ID: 37335759
[No Abstract] [Full Text] [Related]
16. Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.
Sala-Mira I; Garcia P; Díez JL; Bondia J
Comput Methods Programs Biomed; 2022 Nov; 226():107061. PubMed ID: 36116400
[TBL] [Abstract][Full Text] [Related]
17. Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.
Cameron FM; Ly TT; Buckingham BA; Maahs DM; Forlenza GP; Levy CJ; Lam D; Clinton P; Messer LH; Westfall E; Levister C; Xie YY; Baysal N; Howsmon D; Patek SD; Bequette BW
Diabetes Technol Ther; 2017 Sep; 19(9):527-532. PubMed ID: 28767276
[TBL] [Abstract][Full Text] [Related]
18. Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management.
Luijf YM; DeVries JH; Zwinderman K; Leelarathna L; Nodale M; Caldwell K; Kumareswaran K; Elleri D; Allen JM; Wilinska ME; Evans ML; Hovorka R; Doll W; Ellmerer M; Mader JK; Renard E; Place J; Farret A; Cobelli C; Del Favero S; Dalla Man C; Avogaro A; Bruttomesso D; Filippi A; Scotton R; Magni L; Lanzola G; Di Palma F; Soru P; Toffanin C; De Nicolao G; Arnolds S; Benesch C; Heinemann L;
Diabetes Care; 2013 Dec; 36(12):3882-7. PubMed ID: 24170747
[TBL] [Abstract][Full Text] [Related]
19. Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.
Cameron F; Niemeyer G; Wilson DM; Bequette BW; Benassi KS; Clinton P; Buckingham BA
Diabetes Technol Ther; 2014 Nov; 16(11):728-34. PubMed ID: 25259939
[TBL] [Abstract][Full Text] [Related]
20. First Outpatient Clinical Trial of a Full Closed-Loop Artificial Pancreas System in South America.
Garelli F; Fushimi E; Rosales N; Arambarri D; Mendoza L; Serafini MC; Moscoso-Vásquez M; Stasi M; Duette P; García-Arabehety J; Giunta JN; De Battista H; Sánchez-Peña R; Grosembacher L
J Diabetes Sci Technol; 2023 Jul; 17(4):1008-1015. PubMed ID: 35549733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]